Advanced drug delivery systems targeting NF-κB in respiratory diseases (2021)
Prasher, Parteek 
; Sharma, Mousmee ; Chellappan, Dinesh Kumar ; Gupta, Gaurav ; Jha, Niraj Kumar; Singh, Sachin Kumar; MacLoughlin, Ronan ; Pinto, Terezinha de Jesus Andreoli ; Löbenberg, Raimar ; Dua, Kamal
Source: Future Medicinal Chemistry. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, v. 13, n. 13, p. 1087-1090, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0013. Acesso em: 11 nov. 2024.APA
Prasher, P., Sharma, M., Chellappan, D. K., Gupta, G., Jha, N. K., Singh, S. K., et al. (2021). Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, 13( 13), 1087-1090. doi:10.4155/fmc-2021-0013NLM
Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2024 nov. 11 ] Available from: https://doi.org/10.4155/fmc-2021-0013Vancouver
Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2024 nov. 11 ] Available from: https://doi.org/10.4155/fmc-2021-0013
